Below are internal funding opportunities that have been submitted from centers and institutes across Johns Hopkins University. Please note that this may not be an all-inclusive list of internal opportunities. If you have an opportunity you would like us to publicize here and in the monthly digest email, please fill out this form by the last Wednesday of each month for inclusion in the following digest.
If you would like to be added to the monthly internal funding opportunity announcement listserv, please contact RDT.
INTERNAL FUNDING OPPORTUNITIES FOR SEPTEMBER 2, 2020
|Funding Sponsor||Program Title||Max Amount of Award||Due Date||Notification Date|
|Center for Innovation in Graduate Biomedical Education||Johns Hopkins-GlaxoSmithKline Scholars Program||TBD after application review with GSK||Rolling until program reaches capacity||TBD|
|As part of our ongoing efforts to expand PhD training program driven by academia-industry collaboration, we are soliciting proposals from Johns Hopkins investigators interested in working with investigators at GlaxoSmithKline (GSK) Vaccines (Rockville, MD) to mentor JHU graduate students pursuing a Ph.D. degree in the biomedical sciences.
Eligibility: Johns Hopkins investigators affiliated with at least one Ph.D.-granting program at any of the schools of the Johns Hopkins University. Investigators who do not currently mentor graduate students are also encouraged to apply as long as they are eligible to mentor Ph.D. candidates.
|Kavli Neuroscience Discovery Institute||Visiting Scientist Program||$7,000||Rolling basis||Rolling basis|
|The primary goal of the Kavli Neuroscience Discovery Institute (Kavli NDI) Visiting Scientist Program is to enrich research at JHU by supporting short-term visits by external scientists to JHU laboratories. The program will promote scholarly exchange and establish new collaborations between the visiting scholars and the JHU community. This call invites proposals from current faculty of JHU to invite a non-JHU affiliated scientist to spend a minimum of one week at JHU. JHU faculty host applicants should contact their prospective candidate visitor directly to develop their proposal prior to submitting an application. To increase impact, it is expected that the Kavli Visiting Scientist will interact with the broader JHU community during the visit, by presenting a seminar or hosting a workshop, and chairing a discussion group.
Eligibility: The Kavli Visiting Scientist Program encourages applications from current full-time faculty members of Johns Hopkins University to host a national or international scientist. JHU faculty should propose a well-defined scientific justification to promote potential collaborations between the visiting scientist with JHU Faculty that is aligned with the mission of the Kavli NDI.
|The Sol Goldman Pancreatic Cancer Research Center||Pilot Projects||$100,000||September 4, 2020||TBA|
|The Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins is pleased to announce that funding is available for a limited number of novel developmental research programs (pilot projects) in the study of adenocarcinoma of the pancreas. This program funds important new pilot projects with promising translational potential that do not have sufficient data for an independently funded NIH grant. Projects of high priority should focus on new research directions, explore innovative ideas, test unconventional, but potentially important, new hypotheses, or ascertain the feasibility of new research approaches. Applications are due Friday, September 4, 2020 at 5:00 p.m.
Eligibility: Applicants must hold an MD or PhD degree or both and must have a current academic appointment at Johns Hopkins University. Individuals with nontenure track positions should provide a letter from a tenure track faculty member describing their position and providing assurances of employment during the grant period.
|Pfizer’s Centers for Therapeutic Innovation (CTI)||Call for Proposals||unspecified||September 21, 2020||Rolling Basis|
|Pfizer’s Centers for Therapeutic Innovation, or CTI, is a unique joint drug discovery model focused on collaborating with leading academic medical centers to rapidly translate novel target opportunities into new medicines.
In collaboration with JHTV, Pfizer CTI requests proposals for therapeutic targets. Submission entails a non-confidential 2-3 page overview of the target, mechanism, evidence for disease linkage, and the proposed therapeutic drug. At a high level, the pre-proposal should suggest how the therapeutic hypothesis could be tested in the clinic. The CTI 2020 Call for Proposals (CFP) is focused on identifying novel therapeutic opportunities in the areas outlined below with application in Pfizer’s core research focus areas: oncology, inflammation & immunology, internal medicine and rare diseases. Areas of Interest: DNA Damage Response and Replicative Stress; Repeat Expansion Diseases; Cellular Senescence; Tissue-Immune System Crosstalk.
Eligibility: All researchers and clinicians whose work meets these criteria are invited to apply.
|Office of the Vice Provost for Research||Discovery Awards||$100,000||September 28, 2020||TBA|
|More than ever, the answers to the most challenging questions cannot be accomplished entirely within one academic discipline, or even one division. The Johns Hopkins Discovery Awards provide grant awards to cross-divisional teams, comprised of faculty and/or non-faculty members from at least two schools or affiliates of the university, who are poised to arrive at important discoveries or creative works. The expectation is that these awards will spark new, synergistic interactions between investigators across the institution and lead to work of the highest quality and impact. These awards are not intended to support already established projects or minimal extensions of ongoing research or professional programs.
Eligibility: Only one application per lead PI will be accepted. There is no limit to the number of proposals you can participate in as a co-PI. If you were the lead PI of a funded 2019 Discovery Award, you are not eligible to apply as the lead PI of a 2020 award. You will be eligible again in 2021. Approximately three of the 30 awards will be in research related to climate change. Approximately five of the 30 awards will be in research related to artificial intelligence. Applications from all academic and professional disciplines at the university are welcome, and may cover fundamental, applied, or clinical research in any field, as well as the development of applied creative projects in the arts and humanities. Applications must include at least two faculty members and/or APL staff members representing at least two separate schools/divisions or affiliates of the university.
|Office of the Vice Provost for Research||2021 Presidential Frontier Awards||$250,000||November 2, 2020||TBA|
|President’s Frontier Award recipients are selected via an annual university-wide competition for demonstrating significant scholarly achievement and showing exceptional promise for important future work. The $250,000 award will recognize one person each year for five years with a funding for their research expenses.
Eligibility: A full-time faculty member in any division who has demonstrated exceptional scholarly achievement and for whom the award will significantly expand their prominence as an intellectual leader within their relevant fields of study. The ideal candidate will be a mid-career, full-time faculty member.